Alkeuspharma
Cambridge, US · Founded 2010 · 57 employees on LinkedIn · 4 known investors
Find your way into Alkeuspharma
Sign up to see every warm intro you have to Alkeuspharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alkeuspharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Alkeus Pharma develops therapies for retinal diseases, including inherited and neovascular conditions. The company focuses on gene therapies and other advanced treatment modalities for ophthalmology.
Founders & leadership

Investors · 4
How we know: Bain Capital Life Sciences's portfolio page · Not right? Tell us
How we know: Sofinnova Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
Related companies · 1
Companies working in the same space as Alkeuspharma.
Frequently asked questions
- What does Alkeuspharma do?
- Alkeus Pharma develops therapies for retinal diseases, including inherited and neovascular conditions. The company focuses on gene therapies and other advanced treatment modalities for ophthalmology.
- Who are Alkeuspharma's investors?
- Alkeuspharma's investors include Bain Capital Life Sciences, Sofinnova Ventures, TCG Crossover, Wellington Management.
- Where is Alkeuspharma headquartered?
- Alkeuspharma is headquartered in Cambridge, US.



